To include your compound in the COVID-19 Resource Center, submit it here.

Allervax Ragweed peptide immunotherapy: Began Phase II trials in 150 allergic patients, using nasal, conjunctival, and bronchial challenge. The bronchial challe

ImmuLogic Pharmaceutical Corp. (IMUL), Waltham,

Read the full 57 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE